Insider trades
Bonstein Sara, Director of Xilio Therapeutics XLO, has filed 0 purchases and 37 sales on the open market. Over the past 12 months that comes to a net sale of $2.1M. The latest trade was on 06/11.
Bonstein Sara
Director
- Company
- Xilio Therapeutics XLO
- First filing
- 23/01/12
- Trades
- 113 trades
- Buys / sales
- 0 / 37
- 12-month net buying
- −$2.1M
- Last trade
- 06/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
InsmedINSM | Open-market sale | 06/03 | 06/05 | 2,404 sh | $102.27 | $245,857.08 | −3.4% |
InsmedINSM | Open-market sale | 05/13 | 05/15 | 8,272 sh | $116.18 | $961,040.96 | −10.4% |
InsmedINSM | Open-market sale | 02/03 | 02/04 | 748 sh | $156.34 | $116,942.32 | −0.9% |
| Open-market sale | 01/06–01/08 | 01/08 | 4,642 sh3 trades | $174.22avg. | $808,733.06 | −5.5% | |
| Open-market sale10b5-1 plan | 25/07/21 | 25/07/23 | 58,400 sh2 trades | $102.67avg. | $5,996,093.5 | −44.3% | |
| Open-market sale10b5-1 plan | 25/07/07 | 25/07/09 | 57,764 sh2 trades | $95.86avg. | $5,537,460.17 | −40.7% | |
| Open-market sale10b5-1 plan | 25/06/23 | 25/06/25 | 57,765 sh2 trades | $101.78avg. | $5,879,088.99 | −38.2% | |
| Open-market sale10b5-1 plan | 25/06/10 | 25/06/12 | 57,766 sh6 trades | $89.12avg. | $5,148,024.17 | −35.8% | |
InsmedINSM | Open-market sale | 25/06/03 | 25/06/04 | 1,579 sh | $71.50 | $112,898.5 | −1.4% |
| Open-market sale | 25/05/13–25/05/14 | 25/05/15 | 10,504 sh2 trades | $67.47avg. | $708,681.44 | −8.8% | |
| Open-market sale10b5-1 plan | 25/02/18 | 25/02/20 | 18,322 sh2 trades | $80.31avg. | $1,471,394.16 | −13.4% | |
| Open-market sale10b5-1 plan | 25/02/11–25/02/12 | 25/02/13 | 18,321 sh2 trades | $80.00avg. | $1,465,680 | −11.8% | |
InsmedINSM | Open-market sale | 25/02/06 | 25/02/07 | 28,390 sh | $80.90 | $2,296,751 | −15.4% |
| Open-market sale | 25/01/07–25/01/10 | 25/01/10 | 6,000 sh3 trades | $65.43avg. | $392,601.72 | −4.8% | |
| Open-market sale10b5-1 plan | 24/05/28–24/05/29 | 24/05/30 | 241,288 sh2 trades | $50.00avg. | $12,064,607.24 | −67.3% | |
InsmedINSM | Open-market sale | 24/05/14 | 24/05/15 | 11,088 sh | $25.32 | $280,748.16 | −8.6% |
InsmedINSM | Open-market sale | 24/01/09 | 24/01/11 | 4,497 sh | $29.18 | $131,222.46 | −3.8% |
InsmedINSM | Open-market sale10b5-1 plan | 23/12/22 | 23/12/22 | 13,199 sh | $30.00 | $395,970 | −11.1% |
| Open-market sale | 23/05/15–23/05/16 | 23/05/17 | 3,820 sh2 trades | $18.95avg. | $72,389.7 | −3.1% | |
InsmedINSM | Open-market sale | 23/01/10 | 23/01/12 | 2,857 sh | $18.12 | $51,768.84 | −4.1% |